Currently, defective MMR genes such as MLH1, MSH2, MSH6, and PMS2 can be detected in tumor and normal tissues (usually blood or adjacent normal tissues) using immunohistochemistry (IHC) and polymerase chain reaction (PCR) (14). This evidence concerns the gene MRC1 and neoplasm.